Agustin Melo Carrillo, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nociceptors | 4 | 2019 | 432 | 1.610 |
Why?
|
| Calcitonin Gene-Related Peptide | 3 | 2019 | 306 | 1.170 |
Why?
|
| Cortical Spreading Depression | 5 | 2019 | 276 | 1.020 |
Why?
|
| Nerve Fibers, Unmyelinated | 2 | 2019 | 98 | 0.760 |
Why?
|
| Meninges | 2 | 2019 | 190 | 0.720 |
Why?
|
| Trigeminal Nucleus, Spinal | 1 | 2017 | 18 | 0.610 |
Why?
|
| Neuromuscular Agents | 1 | 2019 | 134 | 0.610 |
Why?
|
| Trigeminal Nerve | 1 | 2019 | 249 | 0.610 |
Why?
|
| Migraine Disorders | 4 | 2019 | 1620 | 0.600 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2019 | 213 | 0.550 |
Why?
|
| Myelin Sheath | 1 | 2017 | 652 | 0.460 |
Why?
|
| Antibodies, Monoclonal | 3 | 2019 | 9274 | 0.420 |
Why?
|
| Cardiovascular System | 1 | 2019 | 832 | 0.400 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2017 | 957 | 0.400 |
Why?
|
| Dura Mater | 2 | 2019 | 291 | 0.280 |
Why?
|
| Cerebral Arteries | 2 | 2019 | 494 | 0.260 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2019 | 8301 | 0.260 |
Why?
|
| Behavior, Animal | 1 | 2013 | 1881 | 0.250 |
Why?
|
| Rats | 4 | 2019 | 24260 | 0.160 |
Why?
|
| Students, Medical | 1 | 2011 | 1862 | 0.160 |
Why?
|
| Pia Mater | 1 | 2018 | 88 | 0.150 |
Why?
|
| Migraine with Aura | 1 | 2019 | 203 | 0.140 |
Why?
|
| Diclofenac | 1 | 2017 | 71 | 0.140 |
Why?
|
| Ganglia, Spinal | 1 | 2019 | 519 | 0.140 |
Why?
|
| Cerebral Veins | 1 | 2017 | 156 | 0.130 |
Why?
|
| Extracellular Fluid | 1 | 2017 | 167 | 0.130 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2017 | 371 | 0.130 |
Why?
|
| Vasodilation | 1 | 2019 | 944 | 0.130 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 18029 | 0.120 |
Why?
|
| Irritants | 1 | 2013 | 44 | 0.110 |
Why?
|
| Hyperalgesia | 1 | 2017 | 502 | 0.110 |
Why?
|
| Depression | 1 | 2011 | 7766 | 0.100 |
Why?
|
| Neural Pathways | 2 | 2019 | 2972 | 0.100 |
Why?
|
| Headache | 1 | 2019 | 1226 | 0.100 |
Why?
|
| Mexico | 1 | 2011 | 690 | 0.090 |
Why?
|
| Rats, Wistar | 1 | 2013 | 1901 | 0.080 |
Why?
|
| Animals | 8 | 2019 | 168757 | 0.080 |
Why?
|
| Psychotherapy, Group | 1 | 2011 | 406 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2018 | 2725 | 0.070 |
Why?
|
| Macrophages | 1 | 2018 | 5655 | 0.060 |
Why?
|
| Psychotherapy | 1 | 2011 | 1643 | 0.050 |
Why?
|
| Male | 7 | 2019 | 350118 | 0.050 |
Why?
|
| Neurons | 1 | 2019 | 9338 | 0.040 |
Why?
|
| Neuroanatomical Tract-Tracing Techniques | 1 | 2019 | 40 | 0.040 |
Why?
|
| Female | 7 | 2019 | 380194 | 0.040 |
Why?
|
| TRPV Cation Channels | 1 | 2018 | 236 | 0.040 |
Why?
|
| Prevalence | 1 | 2011 | 15226 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2019 | 2274 | 0.030 |
Why?
|
| Cerebrospinal Fluid | 1 | 2017 | 534 | 0.030 |
Why?
|
| Humans | 5 | 2019 | 744343 | 0.030 |
Why?
|
| Brain | 1 | 2017 | 26385 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 21827 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2017 | 3420 | 0.020 |
Why?
|
| Mice | 3 | 2019 | 81183 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 9734 | 0.020 |
Why?
|
| Skin | 1 | 2017 | 4364 | 0.010 |
Why?
|
| Adult | 2 | 2017 | 214055 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2017 | 53288 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 56430 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 63114 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 85781 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 213383 | 0.000 |
Why?
|